If you have spent any time around performance athletes or tactical operators over the last five years, you have heard about BPC-157. It has quietly become one of the most requested peptides in wellness clinics — and for good reason.
BPC stands for Body Protection Compound. It is a synthetic fragment of a protein originally isolated from human gastric juice, and it appears to accelerate healing in tissues that are notoriously slow to repair: tendons, ligaments, gut lining, and vascular tissue.
Here is what the current research shows, how clinicians use it, and where the honest limits are.
What BPC-157 Actually Does
The best-supported mechanism is angiogenesis: BPC-157 promotes the formation of new blood vessels at injury sites. More blood flow means more oxygen, more nutrients, and faster clearance of inflammatory byproducts — the exact bottleneck that keeps tendon and ligament injuries stuck for months.
Animal studies have shown accelerated healing of Achilles tendon transections, medial collateral ligament tears, muscle crush injuries, and gastrointestinal ulcers. Human data is more limited, but clinical case reports and years of clinician experience consistently point in the same direction.
The Injuries It Is Used For
In real-world protocols, BPC-157 is used most often for chronic tendinopathies (golfer's elbow, tennis elbow, patellar tendinopathy, plantar fasciitis), post-surgical recovery, ligament sprains, and stubborn gut issues including reflux, IBS, and NSAID-induced gastritis.
Athletes and first responders often use it after high-impact events — a bad shift with lots of lifting, a training block that beat up the joints, or an acute injury that would normally sideline them for weeks.
How It Is Dosed
Typical clinical protocols run 250 to 500 mcg per day via subcutaneous injection, split into one or two daily doses, for cycles of four to eight weeks. Injection is usually placed near the site of injury when possible, though systemic dosing also produces results.
Cycles are followed by breaks. BPC-157 is not designed for continuous year-round use. Summit protocols include structured on/off cycling and are always paired with the physical therapy or training work required to actually rebuild the tissue.
Safety and What We Do Not Know
Short-term safety data in humans is favorable. Reported side effects are rare and typically mild — some patients notice mild injection-site irritation or transient fatigue during the first few days.
The honest limit: BPC-157 has not been approved by the FDA for any indication, and long-term safety data in humans is limited. This is why prescription access through a licensed clinician using US-based 503A compounding pharmacies matters. Buying peptides from unregulated online vendors is a real risk.
Where It Fits in a Real Recovery Plan
BPC-157 is a powerful accelerator, not a replacement for the actual work of rehab. Progressive tendon loading, mobility work, sleep, and protein intake still drive the majority of tissue healing.
The peptide gives you a bigger and faster window to do that work. Summit protocols pair BPC-157 with training and recovery guidance from the coaches at our partner facilities, so the tissue is not just healing faster — it is coming back stronger.
Recover Like the Job Depends On It
Get a personalized peptide protocol built around your training, your work, and your history of injury.
Start Your Consultation